| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_616f7b1d1b9e3c904aba8ff2513922e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_460ac56766516d38aa02f27b21b531e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2013-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f007044c782c3cfb7cd5a4e13734b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5c1cb65d4bd90e9995b76c7290d45b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e880cadab24ecca024103f714ea0bd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d28a5ee0520508cd3793014400f6da3d |
| publicationDate |
2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9138411-B2 |
| titleOfInvention |
Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy |
| abstract |
The present invention includes compositions and methods of making a nanoparticle composition comprising a polymeric core comprising one or more polymers and one or more active agents, and at least one layer of one or more lipids on the surface of the polymeric core; more specifically, the invention relates to the use of curcumin within such a lipid-polymer nanoparticle formulation for minimizing QT prolongation associated with curcumin in treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10258691-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10117881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10349884-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617639-B2 |
| priorityDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |